These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 10206307)

  • 1. p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer.
    Anttila MA; Kosma VM; Hongxiu J; Puolakka J; Juhola M; Saarikoski S; Syrjänen K
    Br J Cancer; 1999 Apr; 79(11-12):1870-8. PubMed ID: 10206307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of p21(WAF1) and its relationship with p53 and PCNA protein in epithelial ovarian cancer].
    Yan XJ; Liang LZ; Li DC; Li JL; Zhang CQ; Yuan SH
    Ai Zheng; 2004 Jan; 23(1):74-80. PubMed ID: 14720380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of p53 and p21(waf1/cip1) immunoreactivity in epithelial cancers of the ovary.
    Werness BA; Freedman AN; Piver MS; Romero-Gutierrez M; Petrow E
    Gynecol Oncol; 1999 Dec; 75(3):413-8. PubMed ID: 10600299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p21 (WAF1/CIP1) protein expression is associated with prolonged survival but not with p53 expression in epithelial ovarian carcinoma.
    Schmider A; Gee C; Friedmann W; Lukas JJ; Press MF; Lichtenegger W; Reles A
    Gynecol Oncol; 2000 May; 77(2):237-42. PubMed ID: 10785471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer.
    Bali A; O'Brien PM; Edwards LS; Sutherland RL; Hacker NF; Henshall SM
    Clin Cancer Res; 2004 Aug; 10(15):5168-77. PubMed ID: 15297421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.
    Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K; Kosma VM
    Br J Cancer; 1999 Aug; 80(12):2001-7. PubMed ID: 10471053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
    Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
    Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferation- and apoptosis-associated factors in advanced prostatic carcinomas before and after androgen deprivation therapy: prognostic significance of p21/WAF1/CIP1 expression.
    Baretton GB; Klenk U; Diebold J; Schmeller N; Löhrs U
    Br J Cancer; 1999 May; 80(3-4):546-55. PubMed ID: 10408865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
    Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
    Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p21(WAF1/CIP1) expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival.
    Karjalainen JM; Eskelinen MJ; Kellokoski JK; Reinikainen M; Alhava EM; Kosma VM
    Br J Cancer; 1999 Feb; 79(5-6):895-902. PubMed ID: 10070887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy.
    Levesque MA; Katsaros D; Massobrio M; Genta F; Yu H; Richiardi G; Fracchioli S; Durando A; Arisio R; Diamandis EP
    Clin Cancer Res; 2000 Aug; 6(8):3260-70. PubMed ID: 10955812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
    Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
    Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and significance of tumor suppressor gene WAF1 in epithelial ovarian neoplasms].
    Cao L; Yang Z; Li X
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(6):602-4. PubMed ID: 10806783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p53, p21WAF1/CIP1, p16INK4A and Ki-67 proteins in serous ovarian tumors.
    Buchynska LG; Nesina IP; Yurchenko NP; Bilyk OO; Grinkevych VN; Svintitsky VS
    Exp Oncol; 2007 Mar; 29(1):49-53. PubMed ID: 17431389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p21WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma.
    Nemes JA; Nemes Z; Márton IJ
    J Oral Pathol Med; 2005 May; 34(5):274-9. PubMed ID: 15817070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p22/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis.
    Ropponen KM; Kellokoski JK; Lipponen PK; Pietiläinen T; Eskelinen MJ; Alhava EM; Kosma VM
    Br J Cancer; 1999 Sep; 81(1):133-40. PubMed ID: 10487624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection.
    Kao JT; Chuah SK; Huang CC; Chen CL; Wang CC; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH
    Liver Int; 2007 Aug; 27(6):772-81. PubMed ID: 17617120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival.
    Rosen DG; Wang L; Jain AN; Lu KH; Luo RZ; Yu Y; Liu J; Bast RC
    Clin Cancer Res; 2004 Oct; 10(19):6559-66. PubMed ID: 15475444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of p21(WAF1/CIP1) and p53 expression in serous cystadenocarcinoma of the ovary.
    Terauchi F; Okamoto A; Nagashima T; Kobayashi Y; Moritake T; Yamamoto Y; Takakura S; Iwaki S; Ogura H
    Oncol Rep; 2005 Aug; 14(2):363-8. PubMed ID: 16012716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p21 expression predicts outcome in p53-null ovarian carcinoma.
    Rose SL; Goodheart MJ; DeYoung BR; Smith BJ; Buller RE
    Clin Cancer Res; 2003 Mar; 9(3):1028-32. PubMed ID: 12631602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.